Letter Regarding

Cover Letter regarding Modification of Manuscript Ms

Response letter regarding the letter to the editors by Brown et al.

We read with interest the letter by Brown and colleagues, which focuses on our model’s assumptions regarding duration of cross-protection against non-vaccine HPV types (20, 30, 50 y and lifetime). Brown et al. begin by highlighting an article reviewing cross protection in different vaccine trials by Malag on et al., which suggests that AS04-adjuvanted HPV16/18 (bHPV, CervarixTM) vaccine-mediate...

Letter regarding: "Paraquat: the red herring of Parkinson's disease research".

We write this letter in response to the recent editorial entitled ‘‘Paraquat: the Red Herring of Parkinson’s Disease Research’’ by G. W. Miller. In our opinion, this editorial fails to appreciate that Parkinson’s disease (PD) is a complex disease with multiple interactive etiologic risk factors and that our current animals models, as imperfect as they may be (is there such thing as a ‘‘perfect’...

Reply to Letter to the Editor regarding anaplastic thyroid carcinoma.

To the Editor: We are grateful to Drs. Cabanillas and Williams for their correspondence. They raise the important clinical entity of anaplastic thyroid cancer (ATC). ATC presents a difficult management challenge for the multidisciplinary team, with a woeful prognosis. Indeed, we recognize that ATC can be confused with a squamoid pattern and may arise from a papillary primary. We accept that the...

Letter by Sanna Regarding Article, "Prognostications of Fibrillations".

Letter by Sanna Regarding Article, “Prognostications of Fibrillations” To the Editor: We read with great interest the article by Silver and Windecker but were concerned about a mistake on the reference of our study. The last sentence at the end of the first paragraph states “Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event (EMBRACE) followed a small number of...